logo
AAT Bioquest

Cyclin-dependent kinase 5 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
SeliciclibIC50160.0 [1], 1069.0 [2]
DinaciclibIC501.0 [1], 45.0 [2]
6-Bromoindirubin-3'-oximeIC5083.0 [1], 85.0 [2]
OlomoucineIC503000.0 [1]
7-Bromo-3-[3-(hydroxyamino)-1H-indol-2-yl]indol-2-oneIC5010000.0 [1], 33000.0 [2]
TofacitinibIC5010000.0 [1]
2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanolIC50160.0 [1]
PalbociclibIC5010000.0 [1]
N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)ureaIC50100000.0 [1]
AlsterpaulloneIC5040.0 [1]
SulfuretinIC501500.0 [1]
(3Z)-3-(1H-Imidazol-5-ylmethylene)-5-methoxy-1H-indol-2(3H)-oneIC5065.0 [1]
HymenialdisineIC5030.0 [1]
4-({5-Amino-1-[(2,6-Difluorophenyl)carbonyl]-1h-1,2,4-Triazol-3-Yl}amino)benzenesulfonamideIC5012.59 [1]
2-(Pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-oneIC50460.0 [1]
6-O-Cyclohexylmethyl guanineIC5097000.0 [1]
(16E)-14-Methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaeneIC503.0 [1]
O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purineIC50480.0 [1]
BS-181IC503700.0 [1]
Aigialomycin DIC506000.0 [1]
3-(2-Aminopyrimidin-4-yl)-1H-indol-4-olIC503500.0 [1]
JNK Inhibitor VIIIKi9300.0 [1]
4-Methyl-3-(2-((2-morpholinoethyl)amino)quinazolin-6-yl)-N-(3-(trifluoromethyl)phenyl)benzamideIC5025000.0 [1]
Pyrimidone, 22IC50100000.0 [1]
2-(4-Fluoroanilino)-5-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-3-methylpyrimidin-4-oneIC50100000.0 [1]
(2R)-2-({9-(1-Methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-olIC50225.0 [1]
4-[[6-(Ethylamino)-2-[[1-(phenylmethyl)-5-indolyl]amino]-4-pyrimidinyl]amino]-1-cyclohexanolIC5025000.0 [1]
PalinurinIC5025000.0 [1]
N-(3-Cyclopropyl-1H-pyrazol-5-YL)-2-(2-naphthyl)acetamideIC50114.0 [1]
7-Bromo-1-methyl-3-(3-nitroso-1H-indol-2-yl)indol-2-olIC5010000.0 [1]
6,11-Dihydroxy-3,3-dimethyl-12H-pyrano[2,3-c]acridin-7-oneIC5010000.0 [1]
N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamideKi9300.0 [1]
Lck InhibitorIC5010000.0 [1]
2-(7-Bromo-2-hydroxy-1H-indol-3-yl)-3-nitroso-1H-indole-6-carboxylic acidIC5010000.0 [1]
2-(7-Bromo-2-hydroxy-1H-indol-3-yl)-5-[(E)-hydroxyiminomethyl]indol-3-oneIC50200.0 [1]
3-(3-Nitroso-1H-indol-2-yl)-7-(trifluoromethyl)-1H-indol-2-olIC5010000.0 [1]
Methyl 2-(7-bromo-2-hydroxy-1H-indol-3-yl)-3-nitroso-1H-indole-5-carboxylateIC5010000.0 [1]
4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamideKi9300.0 [1]
7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrileKi9275.0 [1]
1-[6-(4-Methoxybenzylamino)-9-isopropyl-9H-purine-2-yl]-3-methyl-1-pentyne-3-olIC50400.0 [1]
C-2 Alkynylated purine deriv. 2cIC50340.0 [1]
C-2 Alkynylated purine deriv. 4eIC50230.0 [1]
3-[2-(Pyridin-4-yl)-1,3-thiazol-4-yl]-1,2-dihydroquinolin-2-oneIC5054.0 [1]
3-(3,4-Dimethoxyphenyl)pyrrolo[2,3-b]pyrrolizin-8(1H)-oneIC5050000.0 [1]
3-(3,4-Dimethoxy-phenyl)-furo[2,3-b]pyrrolizin-8-oneIC5050000.0 [1]
N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamideKi9300.0 [1]
N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamideKi9300.0 [1]
N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamideKi9300.0 [1]
N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamideKi9300.0 [1]
3-[2-(Pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-oneIC5079.0 [1]
Acylsemicarbazide deriv. 3aaIC505.0 [1]
2-(7-Bromo-2-hydroxy-1-methylindol-3-yl)indol-3-oneIC5010000.0 [1]
(2z,3e)-7'-Bromo-3-(Hydroxyimino)-2'-Oxo-1,1',2',3-Tetrahydro-2,3'-Biindole-5-Carboxylic AcidIC5010000.0 [1]
2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-5-carbonitrileIC5010000.0 [1]
Methyl 2-(7-bromo-2-hydroxy-1H-indol-3-yl)-3-oxoindole-5-carboxylateIC5010000.0 [1]
Methyl 2-[2-hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-oxoindole-5-carboxylateIC5010000.0 [1]
2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-oxoindole-5-carbonitrileIC5010000.0 [1]
Methyl 2-(7-bromo-2-hydroxy-1-methylindol-3-yl)-3-oxoindole-5-carboxylateIC5010000.0 [1]
Methyl 2-(7-bromo-2-hydroxy-1H-indol-3-yl)-3-oxoindole-6-carboxylateIC5010000.0 [1]
Methyl 2-[2-hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-oxoindole-6-carboxylateIC5010000.0 [1]
2-(7-Bromo-2-hydroxy-1H-indol-3-yl)-3-oxoindole-6-carboxylic acidIC5010000.0 [1]
2-(2-Hydroxy-1H-indol-3-yl)-3-nitroso-1H-indole-5-carboxylic acidIC50530.0 [1]
Methyl 2-[2-hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-5-carboxylateIC5010000.0 [1]
2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-5-carboxylic acidIC501600.0 [1]
Methyl 2-(7-bromo-2-hydroxy-1H-indol-3-yl)-3-nitroso-1H-indole-6-carboxylateIC5010000.0 [1]
Methyl 2-[2-hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-6-carboxylateIC501700.0 [1]
2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-6-carboxylic acidIC503100.0 [1]
2-(2-Hydroxy-1H-indol-3-yl)-3-oxoindole-5-carboxylic acidIC503400.0 [1]
2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-5-(2H-tetrazol-5-yl)indol-3-oneIC5010000.0 [1]
3-[3-Nitroso-5-(2H-tetrazol-5-yl)-1H-indol-2-yl]-7-(trifluoromethyl)-1H-indol-2-olIC5010000.0 [1]
4-Methyl-3-[2-(methylamino)quinazolin-6-yl]-N-[2-(1-methylpiperidin-4-yl)oxy-5-(trifluoromethyl)phenyl]benzamideIC5025000.0 [1]
N-[2-[3-(Dimethylamino)propyl-methylamino]-5-(trifluoromethyl)phenyl]-2-fluoro-5-[3-[4-(methylamino)-1,3,5-triazin-2-yl]pyridin-2-yl]oxybenzamideIC50100000.0 [1]
3-[[[5-[1-(4-Methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazol-2-yl]thio]methyl]benzonitrileIC5010000.0 [1]
N-(5-Isopropyl-thiazol-2-yl)-isobutyramideIC50321.0 [1]
N-(5-(2-(Cyclohexyloxy)pyrimidin-4-yl)thiazol-2-yl)pyridin-2-amineIC5034.0 [1]
5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamideIC5010000.0 [1]
N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamideIC501000.0 [1]
4-(4-Fluorophenyl)-N-[4-[3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl]oxyphenyl]phthalazin-1-amineIC5025000.0 [1]
6-Chloro-2-iodo-9-isopropyl-9H-purineIC50100000.0 [1]
C-2 Alkynylated purine deriv. 4dIC50500.0 [1]
C-2 Alkynylated purine deriv. 4fIC50300.0 [1]
C-2 Alkynylated purine deriv. 4gIC50600.0 [1]
C-2 Alkynylated purine deriv. 4hIC50260.0 [1]
C-2 Alkynylated purine deriv. 5aIC50300.0 [1]
C-2 Alkynylated purine deriv. 5bIC50300.0 [1]
C-2 Alkynylated purine deriv. 5cIC50400.0 [1]
C-2 Alkynylated purine deriv. 5dIC50500.0 [1]
C-2 Alkynylated purine deriv. 5eIC50500.0 [1]
5,17-Dihydroxy-4,4,10,10,15-pentamethyl-3,9-dioxa-15-azapentacyclo[12.8.0.02,7.08,13.016,21]docosa-1,5,7,11,13,16(21),17,19-octaen-22-oneIC5010000.0 [1]
1-(5-Cyclobutyl-2-thiazolyl)-3-(5-isoquinolyl)ureaIC508.0 [1]
N-(5-Cyclobutyl-thiazol-2-yl)-2-phenyl-acetamideIC5025.0 [1]
N-(5-Cyclobutyl-thiazol-2-yl)-2-(2-methyl-benzothiazol-6-yl)-acetamideIC5012.0 [1]
8-(Trifluoromethyl)-11H-indolo[3,2-c]quinoline-6-carboxylic acidIC5010000.0 [1]
11H-Indolo[3,2-c]quinoline-6,8-dicarboxylic acidIC5010000.0 [1]
N-(5-Cyclobutyl-thiazol-2-yl)-2-isoquinolin-5-yl-acetamideIC5013.0 [1]
N-(5-Cyclobutyl-thiazol-2-yl)-2-(5,6-dimethyl-benzoimidazol-1-yl)-acetamideIC5013.0 [1]
Ethyl 2-methyl-6-oxo-5-(2-(pyridin-4-yl)thiazol-4-yl)-1,6-dihydropyridine-3-carboxylateIC50131.0 [1]
3-(3-(Benzyloxy)-4-methoxyphenyl)pyrrolo[2,3-b]pyrrolizin-8(1H)-oneIC5050000.0 [1]
3-(3-Hydroxy-4-methoxyphenyl)pyrrolo[2,3-b]pyrrolizin-8(1H)-oneIC5030000.0 [1]
3-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyrrolizin-8-oneIC5050000.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Cyclin-dependent kinase 5 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/cyclin-dependent-kinase-5-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Cyclin-dependent kinase 5 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/cyclin-dependent-kinase-5-inhibitors-ic50-ki.
BibTeXEndNoteRefMan